InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Coherus Oncology, Inc.

CHRS Clue Score53
United States Fiscal year ends December CIK 0001512762
$1.07 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.07 −93.97% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue189.5Operating income−115.9Net income−127.3Fiscal year 2017Revenue1.6 −99.2%Operating income−232.1Net income−238.2EPS, diluted−4.48Fiscal year 2018Revenue0.0 −100.0%Operating income−204.4Net income−209.3EPS, diluted−3.22Fiscal year 2019Revenue356.1Operating income107.8Net income89.8EPS, diluted1.23Fiscal year 2020Revenue475.8 +33.6%Operating income156.3Net income132.2 +47.2%EPS, diluted1.62 +31.7%Fiscal year 2021Revenue326.6 −31.4%Operating income−263.9Net income−287.1 −317.1%EPS, diluted−3.81 −335.2%Fiscal year 2022Revenue211.0 −35.4%Operating income−256.9Net income−291.8EPS, diluted−3.76Fiscal year 2023Revenue257.2 +21.9%Operating income−203.2Net income−237.9EPS, diluted−2.53Fiscal year 2024Revenue26.4 −89.7%Operating income−199.7Net income28.5EPS, diluted0.25Fiscal year 2025Revenue42.2 +59.8%Operating income−181.1Net income168.0 +489.4%EPS, diluted1.43 +472.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 189.5 1.6 0.0 356.1 475.8 326.6 211.0 257.2 26.4 42.2
Growth −99.2% −100.0% +33.6% −31.4% −35.4% +21.9% −89.7% +59.8%
Operating income −115.9 −232.1 −204.4 107.8 156.3 −263.9 −256.9 −203.2 −199.7 −181.1
Net income −127.3 −238.2 −209.3 89.8 132.2 −287.1 −291.8 −237.9 28.5 168.0
Growth +47.2% −317.1% +489.4%
EPS, diluted n/a −4.48 −3.22 1.23 1.62 −3.81 −3.76 −2.53 0.25 1.43
Growth +31.7% −335.2% +472.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−61.2%Net margin−67.2%Free cash flow margin−136.7%Fiscal year 2017Operating margin−14,918.8%Net margin−15,306.6%Free cash flow margin−13,165.7%Fiscal year 2018Fiscal year 2019Operating margin30.3%Net margin25.2%Free cash flow margin7.5%Fiscal year 2020Operating margin32.9%Net margin27.8%Free cash flow margin30.9%Fiscal year 2021Operating margin−80.8%Net margin−87.9%Free cash flow margin−11.9%Fiscal year 2022Operating margin−121.7%Net margin−138.2%Free cash flow margin−115.2%Fiscal year 2023Operating margin−79.0%Net margin−92.5%Free cash flow margin−68.1%Fiscal year 2024Operating margin−756.6%Net margin108.0%Fiscal year 2025Operating margin−429.5%Net margin398.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −61.2% −14,918.8% n/a 30.3% 32.9% −80.8% −121.7% −79.0% −756.6% −429.5%
Net margin −67.2% −15,306.6% n/a 25.2% 27.8% −87.9% −138.2% −92.5% 108.0% 398.4%
Free cash flow margin −136.7% −13,165.7% n/a 7.5% 30.9% −11.9% −115.2% −68.1% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−252.5Capital expenditure−6.5Free cash flow−259.1Fiscal year 2017Operating cash flow−200.3Capital expenditure−4.6Free cash flow−204.9Fiscal year 2018Operating cash flow−159.3Capital expenditure−0.8Free cash flow−160.1Fiscal year 2019Operating cash flow28.4Capital expenditure−1.8Free cash flow26.5Fiscal year 2020Operating cash flow154.1Capital expenditure−7.2Free cash flow146.9 +453.7%Fiscal year 2021Operating cash flow−37.4Capital expenditure−1.3Free cash flow−38.7 −126.4%Fiscal year 2022Operating cash flow−241.1Capital expenditure−2.0Free cash flow−243.2Fiscal year 2023Operating cash flow−174.9Capital expenditure−0.3Free cash flow−175.2Fiscal year 2024Operating cash flow−20.4Fiscal year 2025Operating cash flow−138.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −252.5 −200.3 −159.3 28.4 154.1 −37.4 −241.1 −174.9 −20.4 −138.5
Capital expenditure −6.5 −4.6 −0.8 −1.8 −7.2 −1.3 −2.0 −0.3 n/a n/a
Free cash flow −259.1 −204.9 −160.1 26.5 146.9 −38.7 −243.2 −175.2 n/a n/a
Growth +453.7% −126.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash124.9Shareholders’ equity20.5Fiscal year 2017Cash126.9Shareholders’ equity30.5Fiscal year 2018Cash72.4Total debt0.0Net cash (debt)72.4Shareholders’ equity−38.6Fiscal year 2019Cash177.7Total debt73.7Net cash (debt)104.0Shareholders’ equity105.2Debt to equity0.70Fiscal year 2020Cash541.2Shareholders’ equity281.0Fiscal year 2021Cash417.2Shareholders’ equity97.7Fiscal year 2022Cash63.5Shareholders’ equity−137.4Fiscal year 2023Cash102.9Shareholders’ equity−193.4Fiscal year 2024Cash126.0Shareholders’ equity−132.0Fiscal year 2025Cash88.9Shareholders’ equity61.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 124.9 126.9 72.4 177.7 541.2 417.2 63.5 102.9 126.0 88.9
Total debt n/a n/a 0.0 73.7 n/a n/a n/a n/a n/a n/a
Net cash (debt) n/a n/a 72.4 104.0 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 20.5 30.5 −38.6 105.2 281.0 97.7 −137.4 −193.4 −132.0 61.0
Debt to equity n/a n/a n/a 0.70 n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
189.5 1.6 0.0 356.1 475.8 326.6 211.0 257.2 26.4 42.2
Growth −99.2% −100.0% +33.6% −31.4% −35.4% +21.9% −89.7% +59.8%
n/a n/a n/a 17.1 37.7 57.6 70.1 159.0 8.7 13.8
254.4 162.4 110.2 94.2 142.8 363.1 199.4 109.4 91.8 108.9
51.6 71.3 94.2 137.0 139.1 169.7 198.5 192.0 125.5 100.6
−115.9 −232.1 −204.4 107.8 156.3 −263.9 −256.9 −203.2 −199.7 −181.1
Growth +45.1% −268.8%
n/a −238.3 −209.4 92.8 135.7 −287.1 −291.8 −238.3 −215.4 −183.1
0.0 0.0 0.0 2.9 3.5 0.0 0.0 −0.4 0.0 0.0
−127.3 −238.2 −209.3 89.8 132.2 −287.1 −291.8 −237.9 28.5 168.0
Growth +47.2% −317.1% +489.4%
Per share
n/a −4.48 −3.22 1.29 1.85 −3.81 −3.76 −2.53 0.25 1.43
n/a −4.48 −3.22 1.23 1.62 −3.81 −3.76 −2.53 0.25 1.43
Growth +31.7% −335.2% +472.0%
n/a 53.1 65.0 69.7 71.4 75.4 77.6 94.2 114.6 117.1
n/a 53.1 65.0 73.2 83.5 75.4 77.6 94.2 114.6 117.1
Growth +22.4% +12.5% +14.1% −9.6% +2.9% +21.3% +21.7% +2.3%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 38.4% a year over five years, and earnings per share fell 2.5% a year.
  • The diluted share count rose 40.3% in five years, which is dilution.
  • Operating margin is down 462.4 points on five years ago, at -429.5%.
  • A net loss in 6 of 10 years on file.